Financial results for the period ended September 30, 2026
As filed · Kuantum Papers Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
What happened
FactFinancial results for the period ended September 30, 2026. the Board of Directors and Auditors’ Limited Review Report thereon are attached herewith.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Capex
DelayedKuantum aims to augment the Clonal Propagation Center 's capacity to produce 1 crore clones annually, covering 50,700 acres by 2028-29 to ensure a sustainable source of wood material
The company aims to augment the Clonal Propagation Center's capacity to produce 1 crore clones annually, covering 75,000 acres by 2030 to ensure a sustainable source of wood material.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- The company aims to augment the Clonal Propagation Center's capacity to produce 1 crore clones annually, cover (management committed by FY30)
- The company aims to augment the Clonal Propagation Center's capacity to produce 1 crore clones annually, cover (management committed by FY29)
Evidence
- Kuantum Papers Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.(opens the original filing in a new tab)
- Earlier statement · 9M FY25
- Latest statement · 9M FY26
- Earlier statement · 9M FY26
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +2 corroborating keywords; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%